Nomogram for predicting axillary upstaging in clinical node-negative breast cancer patients receiving neoadjuvant chemotherapy-Reference-Cited by-同舟云学术

Nomogram for predicting axillary upstaging in clinical node-negative breast cancer patients receiving neoadjuvant chemotherapy

Published:2023-05-02 Issue:11 Volume:149 Page:8769-8778
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Maimaitiaili Amina,Chen Heyan,Xie Peiling,Liu Zhenzhen,Ling Rui,Zhao Yi,Yang Hongjian,Liu Yunjiang,Liu Ke,Zhang Jianguo,Mao Dahua,Yu Zhigang,Liu Yinhua,Fu Peifen,Wang Jiandong,Jiang Hongchuan,Zhao Zuowei,Tian Xingsong,Cao Zhongwei,Wu Kejin,Song Ailin,Jin Feng,He Jianjun,Fan Zhimin^ORCID,Zhang Huimin^ORCID

Funder

Institutional Foundation of The First Affiliated Hospital of Xi’an Jiaotong University

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-04817-9.pdf

Reference39 articles.

1. Andersson Y et al (2018) Long-term breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes. Breast Cancer Res Treat 171(2):359–369

2. Asaoka M et al (2020) Neoadjuvant chemotherapy for breast cancer: past, present, and future. Breast Cancer (auckl) 14:1178223420980377

3. Barrio AV et al (2016) How often is treatment effect identified in axillary nodes with a pathologic complete response after neoadjuvant chemotherapy? Ann Surg Oncol 23(11):3475–3480

4. Barron AU et al (2018) Association of low nodal positivity rate among patients with ERBB2-positive or triple-negative breast cancer and breast pathologic complete response to neoadjuvant chemotherapy. JAMA Surg 153(12):1120–1126

5. Boér K et al (2021) Pathologic complete response rates after neoadjuvant pertuzumab and trastuzumab with chemotherapy in early stage HER2-positive breast cancer - increasing rates of breast conserving surgery: a real-world experience. Pathol Oncol Res 27:1609785